Biotech start-up Normunity, Inc. has exited stealth with a $65 million Series A to create a new class of medicines that target novel I-O mechanisms, which free the body’s normal immunity against ...
February 27, 2026 - PRESSADVANTAGE - StoryPop UGC Agency has announced an overview of its user-generated content (UGC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results